Russian President hopes for speedy WHO nod to Sputnik V

Published On 2021-12-06 05:00 GMT | Update On 2021-12-06 12:13 GMT

Moscow: Russian President Vladimir Putin on Sunday voiced hope for a quick approval of the country's Sputnik V coronavirus vaccine by the World Health Organization, saying the move is essential for expanding its global supplies.

Speaking during a video call with Francesco Rocca, president of the International Federation of Red Cross and Red Crescent Societies, Putin said that receiving the WHO's vetting is necessary to spread the Russian vaccine more broadly around the world, including free supplies.

The Russian leader also argued that WHO's approval should open the door for Russians and others who have had the Sputnik V vaccine to travel more freely around the world.

Putin was vaccinated with Sputnik V in the spring, and last month he received a booster shot of Sputnik Light, the one-dose version.

He also said he took an experimental nasal version of Sputnik V days after receiving his booster shot, adding that he was feeling fine and felt no side effects.

The Gamaleya Institute that developed Sputnik V has said the vaccine should be efficient against the omicron variant of Covid-19, but announced that it will immediately start working on adapting it to counter the new variant.

Russia was the first country in the world to authorise a coronavirus vaccine, launching Sputnik V in August 2020, and has plentiful supplies.

But uptake has been slow, blamed in part on conflicting signals from Russian authorities.

Russia in recent months has faced its deadliest and largest surge of coronavirus cases, with infections and deaths climbing to all-time highs and only slowing in the last few weeks.

Russia has Europe's highest confirmed pandemic death toll at over 281,000, according to the government's coronavirus task force.

But a report released Friday by the state statistics agency Rosstat, which uses broader criteria, put the the overall number of virus-linked deaths between April 2020 and October 2021 to over 537,000 — almost twice the official toll.

Putin, who despite a surge in infections in Russia has repeatedly argued that vaccinations should remain voluntary, emphasised Sunday that Russian authorities have been tried to use "persuasion and not pressure" and worked to dispel "prejudices and myths driving the aversion to vaccination."

Russia's quick approval of Sputnik V drew criticism abroad, because at the time it had only been tested on a few dozen people.

But a study published in British medical journal The Lancet in February showed the Sputnik V is 91% effective and appears to prevent inoculated individuals from becoming severely ill with Covid-19.

Russia has actively promoted Sputnik V around the world but faced bottlenecks in shipping the amounts it promised. Countries in Latin America have complained about delays in getting the second Sputnik V shot.

The World Health Organization has been reviewing data about Russia's Sputnik V vaccine as part of the approval process.

Such approval could pave the way for its inclusion into the COVAX programme that is shipping Covid-19 vaccines to scores of countries around the world based on need.

Read also: COVID-19: WHO continues to assess Sputnik V vaccine

Article Source : AP

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Russian President hopes for speedy WHO nod to Sputnik V

Similar News

1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules

CDSCO Panel Nod To MSD's Sotatercept Label Change, Expands Prescribing Rights to Cardiologists

George Tidmarsh named Director of Center for Drug Evaluation and Research: USFDA

Jubilant Ingrevia appoints Ahmad Nadeem Khan as Senior Director - Procurement

Roche announces topline results from trials investigating astegolimab compared to placebo in COPD patients

Alembic Pharma ropes in Dr Sachin Ghosalkar as Sr Vice President - SCM & Operations

State Drug Alert: 130 Batches Found Not of Standard Quality in June; No Data Received from Delhi, Gujarat, UP

Bayer extends CEO Bill Anderson contract until 2029